draft guidance

Blood sample microscope study clinical trial lab research
CRO

FDA issues draft guidance on clinical trial tissue biopsies

The FDA recommends only requiring biopsies if they are needed to determine a patient’s eligibility for the trial or to assess a key endpoint.
Darren Incorvaia Jan 6, 2025 2:55pm
FDA

FDA releases draft guidance on clinical trial diversity

Jun 27, 2024 7:05am
FDA

FDA suggests new tests for morcellator tissue containment tools

Jun 22, 2022 6:25pm
Dementia

FDA ramps up medical device cybersecurity recommendations

Apr 8, 2022 11:50am